SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

SEARCH BY NAME

BROWSE

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

AVITA MEDICAL LTD(AVH)

Click here for free access to this company's:
ASX, Legal & CGT Status

SHARE PRICES

(updated at weekends)

Former (or subsequent) names

 FROMTO
AVITA THERAPEUTICS INC29/06/2020
AVITA MEDICAL LTD26/06/200829/06/2020
CLINICAL CELL CULTURE LIMITED12/11/200226/06/2008
ECAT DEVELOPMENT CAPITAL LIMITED31/08/199912/11/2002
GREENCHIP RESOURCES LIMITED31/08/1999

Shareholder links

Our website ranking of AVH: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Level 11, 172 St Georges Terrace, Perth WA 6000

Tel : +61 (0)3 9415 4000 or 1300 850 505 (within Australia)
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000AVH4
Address: C/- Mertons Corporate Services Pty Ltd Level 7 330 Collins Street Melbourne VIC 3000
Tel:  08 9327 1707 Fax: 08 9327 1778

Date first listed: 09/08/1993
Company Secretary: Mark Licciardo
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Developer of skin and burns treatment.

News & Events

Expand this box to read and print

OFX Transferring Money Internationally to Free

name changed to Avita Therapeutics Inc

29/06/2020

The suspension of trading in the securities of Avita Medical Limited will be lifted immediately following the release of an announcement. ASX Code: AVH

31/08/2015

Avita Medical Ltd. (ASX: AVH), (OTCQX: AVMXY), a regenerative medicine company specializing in the treatment of wounds and skin defects, has been given a high rating to its proposal to a U.S. federal body exploring the possible use of ReCell® under a disaster preparedness programme, the Company said today.

31/08/2015

The securities of Avita Medical Corporation Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. Security Code: AVH

28/08/2015

name changed from Clinical Cell Culture Limited

26/06/2008

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.
Loading comments....  Most recent comments

?

25/12/2017 11:19:10

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    16/09/2020Michael Perry-9,000$27.410$246,690
    15/09/2020Michael Perry-38,861$27.110$1,053,522
    12/09/2020Michael Perry-27,128$26.080$707,498
    02/06/2020Michael Perry-4,953,151$0.481$2,382,961
    05/03/2020Michael Perry-6,434,219$0.621$3,994,685

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Lou PanaccioChairman01/07/2014
    Troy BarringCOO20/06/2016
    David McIntyreCFO18/11/2019
    Louis DrapeauNon Exec Director13/01/2016
    Michael PerryNon Exec Director, CEO06/02/2013
    Suzanne CroweNon Exec Director13/01/2016
    Jeremy CookDirector19/10/2012
    Tim RooneyExecutive

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Damien McDonaldNon Exec Director13/01/201629/10/2020
    Dale SanderCFO05/12/201715/05/2019
    Adam KelliherCEO14/04/201502/06/2017
    Fiona WoodNon Exec Director11/04/200613/01/2016
    Ian MacphersonNon Exec Director05/03/200813/01/2016
    Matthew McNamaraDirector19/10/201213/01/2016
    Dalton GoodingNon Exec Director14/11/200201/07/2014
    William DolphinManaging Director, CEO05/03/200815/12/2013
    Paul WattDirector05/03/200819/10/2012
    Andrew CannonCFO31/12/200431/10/2008
    Marie StonerNon Exec Director19/12/200215/02/2008
    Mark BarnabaNon Exec Director30/03/200514/02/2008
    Bob AtwillCEO17/05/200629/03/2007
    Troels JordansenCEO01/01/200316/05/2006
    David ImperialiNon Exec Director03/05/200411/04/2006
    Harry KarelisNon Exec Director14/08/200325/10/2004
    Paul FletcherNon Exec Director14/11/200229/05/2004
    Philip ReesExecutive Director31/07/2003
    Peter ConstableNon Exec Director14/11/200208/07/2003
    Ludger KohmascherChairman16/09/199914/11/2002
    Adam Rankine-WilsonManaging Director14/11/2002
    David ArcherChairman16/09/199907/03/2002

    Date of first appointment, title may have changed.